ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
ARDELYX, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.09+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $766.53M
- P/E (TTM)
- –
- Dividend yield
- –
Ardelyx statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Ardelyx | Industry median |
|---|---|---|
| Market Cap | $769.99M | $197.05M |
| Enterprise Value | $488.16M | $106.56M |
| PS Ratio | 1.71 | 3.93 |
| PB Ratio | 5.17 | 2.14 |
| P/TBV Ratio | 5.17 | 2.46 |
Enterprise value
| Measure | Ardelyx | Industry median |
|---|---|---|
| EV / Sales | 1.08 | 2.69 |
Income (trailing twelve months)
| Measure | Ardelyx | Industry median |
|---|---|---|
| Revenue | $450.89M | $57.94M |
| Gross Profit | $425.49M | $90.47M |
| Operating Income | -$35.45M | -$21.44M |
| Pretax Income | -$55.48M | -$14.45M |
| Net Income | -$55.70M | -$22.46M |
| EBITDA | -$32.11M | -$16.91M |
| EPS (Diluted) | -$0.22 | -$0.83 |
Margins
| Measure | Ardelyx | Industry median |
|---|---|---|
| Gross Margin | 94.4% | 52.3% |
| Operating Margin | -7.86% | -44.5% |
| Pretax Margin | -12.3% | -13.0% |
| Profit Margin | -12.4% | -39.2% |
| EBITDA Margin | -7.12% | -31.3% |
| FCF Margin | -3.97% | -8.85% |
Returns
| Measure | Ardelyx | Industry median |
|---|---|---|
| Return on Equity (ROE) | -38.6% | -53.1% |
| Return on Assets (ROA) | -10.7% | -41.0% |
| Return on Capital Employed (ROCE) | -7.99% | -37.8% |
Growth
| Measure | Ardelyx | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 16.8% | 6.01% |
| Revenue Growth (3Y CAGR) | 98.4% | 2.25% |
| Revenue Growth (5Y CAGR) | 121.9% | 6.42% |
Balance sheet
| Measure | Ardelyx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $281.83M | $62.42M |
| Net Cash (Debt) | $281.83M | $15.68M |
| Net Cash Per Share | $1.13 | $0.65 |
| Equity (Book Value) | $149.01M | $48.79M |
| Book Value Per Share | $0.60 | $1.36 |
| Tangible Book Value | $149.01M | $23.06M |
| Working Capital | $309.71M | $75.77M |
Financial position
| Measure | Ardelyx | Industry median |
|---|---|---|
| Current Ratio | 3.34 | 3.30 |
| Quick Ratio | 2.89 | 2.39 |
| Interest Coverage | -1.60 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Ardelyx | Industry median |
|---|---|---|
| Operating Cash Flow | -$17.32M | -$12.35M |
| Capital Expenditures | -$599.00K | -$1.06M |
| Free Cash Flow | -$17.92M | -$20.28M |
| FCF Per Share | -$0.07 | -$0.41 |
Efficiency
| Measure | Ardelyx | Industry median |
|---|---|---|
| Asset Turnover | 0.86 | 0.38 |
| Inventory Turnover | 0.19 | 2.67 |
| Revenue Per Employee | $922.07K | $398.96K |
| Profits Per Employee | -$113.91K | -$732.08K |
| Employee Count | 489 | 73 |
Dividends and yields
| Measure | Ardelyx | Industry median |
|---|---|---|
| Earnings Yield | -7.23% | -21.2% |
| FCF Yield | -2.33% | -7.64% |
Shares
| Measure | Ardelyx | Industry median |
|---|---|---|
| Shares Outstanding | 249,188,000 | 59,128,900 |
| Shares Change (YoY) | 2.90% | 11.1% |
| Shares Change (QoQ) | 0.88% | 0.54% |
| Float | 232,047,000 | 48,744,500 |
| Shares Held by Insiders | 6.88% | 11.8% |
| Shares Held by Institutions | 71.2% | 59.4% |
Taxes
| Measure | Ardelyx | Industry median |
|---|---|---|
| Income Tax | $227.00K | $91.50K |
Scores
| Measure | Ardelyx | Industry median |
|---|---|---|
| Altman Z-Score | -0.13 | 0.10 |
| Piotroski F-Score | 3 | 4 |
| Beneish M-Score | -2.36 | -2.62 |
Calculated by StockData from Ardelyx's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.